| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Lalwani Nikhil is a President &CEO at ANIP. Recent filings cover 1 purchase and 12 sales. Those positions are worth an estimated $24.0M at current prices.
Our model assigns Lalwani Nikhil a middling insider score of 66/100, based on 8 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +5.7%.
Lalwani Nikhil's largest disclosed position is in ANIP as President &CEO, worth about $24.0M. The recent filings there lean toward selling, a net 284,625 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | ANIP Ani Pharmaceuticals, Inc. | President &CEO | Sell | 5,400 | $71.89 | $388,206.00 | -1.6% | - | - | |
| Sep 15, 2026 | ANIP Ani Pharmaceuticals, Inc. | President &CEO | Sell | 5,400 | $71.00 | $383,400.00 | -1.6% | - | - | |
| Aug 25, 2026 | ANIP Ani Pharmaceuticals, Inc. | President &CEO | Sell | 5,400 | $74.30 | $401,220.00 | -1.5% | - | - | |
| May 11, 2026 | ANIP Ani Pharmaceuticals, Inc. | President &CEO | Sell | 55,000 | $77.57 | $4,266,350.00 | -13.6% | -3.7% | - | |
| Aug 12, 2025 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sell | 56,960 | $85.93 | $4,894,572.80 | -12.2% | +0.7% | -15.0% | |
| Nov 26, 2024 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sale+OE | 33,481 | $57.99 | $1,941,442.30 | -8.3% | -4.0% | +45.8% | |
| May 14, 2024 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sell | 16,669 | $66.10 | $1,101,820.90 | -4.2% | -9.6% | -8.6% | |
| Mar 8, 2024 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sell | 45,257 | $66.10 | $2,991,468.76 | -9.9% | +2.1% | -10.1% | |
| Aug 15, 2023 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sale+OE | 68,282 | $58.32 | $3,982,547.58 | -16.2% | -16.5% | -4.3% | |
| Mar 21, 2022 | ANIP Ani Pharmaceuticals Inc | President &CEO | Buy | 7,224 | $27.69 | $199,997.16 | +4.4% | -7.0% | +48.0% |